N4 Pharma Plc

(LSE) N4P

Current PriceN/A

Market CapN/A

Since IPO (2017)-91%

5 Year-92%

1 Year+80%

1 Month+42%

N4 Pharma Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$12.93K

Net Income (TTM)

$2.18M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

N4P News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About N4 Pharma Plc

Industry

Pharmaceuticals

Sector

Health Care

CEO

Nigel James Theobald

Website

www.n4pharma.com

Headquarters

London, EC3V 0HR, GB

N4P Financials

Key Financial Metrics (TTM)

Gross Margin

48%

Operating Margin

-161%

Net Income Margin

-156%

Return on Equity

-91%

Return on Capital

-65%

Return on Assets

-60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$7.28K

Operating Income

$1.22M

EBITDA

$1.22M

Operating Cash Flow

$971.50K

Capital Expenditure

$0.00

Free Cash Flow

$971.50K

Cash & ST Invst.

$625.97K

Total Debt

$0.00

N4 Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$3.69K

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$498.55K

+22.8%

EBITDA

$470.22K

+27.2%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$1.73M

+33.9%

Accounts Receivable

$118.11K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-59.74%

N/A

Return on Invested Capital

-64.51%

N/A

Free Cash Flow

$444.37K

+28.9%

Operating Cash Flow

$444.37K

+28.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CHLL.LChill Brands Group PLC

CHLL.LChill Brands Group PLC$0.40+0.00%

PRM.LProteome Sciences plc

PRM.LProteome Sciences plc$1.68+12.00%

TCF.LTheracryf Plc

TCF.LTheracryf Plc$0.22-2.22%

CRTX.LCRISM Therapeutics Corporation

CRTX.LCRISM Therapeutics Corporation$12.75+0.00%

TRX.LTissue Regenix Group plc

TRX.LTissue Regenix Group plc$7.25+0.00%

GDR.LGenedrive Plc

GDR.LGenedrive Plc$0.95+2.70%

FDBK.LFeedback plc

FDBK.LFeedback plc$9.75+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About N4P

What is the current price of N4 Pharma Plc?

N4 Pharma Plc is trading at N/A per share.

What is the 52-week range for N4 Pharma Plc?

Over the past 52 weeks, N4 Pharma Plc has traded between N/A and N/A.

How much debt does N4 Pharma Plc have?

As of the most recent reporting period, N4 Pharma Plc reported total debt of N/A.

How much cash does N4 Pharma Plc have on hand?

N4 Pharma Plc reported $625,972 in cash and cash equivalents in its most recent financial results.

What is N4 Pharma Plc’s dividend yield?

N4 Pharma Plc does not currently have a dividend yield.

N4 Pharma Plc

N4 Pharma Plc Financials at a Glance

N4P News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About N4 Pharma Plc

N4P Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

N4 Pharma Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About N4P

What is the current price of N4 Pharma Plc?

What is the 52-week range for N4 Pharma Plc?

How much debt does N4 Pharma Plc have?

How much cash does N4 Pharma Plc have on hand?

What is N4 Pharma Plc’s dividend yield?

Premium Investing Services